Bio Key International Stock Today
| BKYI Stock | USD 0.92 0.04 4.55% |
Performance1 of 100
| Odds Of DistressOver 80
|
BIO Key is trading at 0.92 as of the 25th of November 2024. This is a 4.55 percent increase since the beginning of the trading day. The stock's open price was 0.88. BIO Key has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for BIO Key International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Software & Services | IPO Date 14th of February 1997 | Category Industrials | Classification Information Technology |
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company has 3.11 M outstanding shares of which 865.18 K shares are currently shorted by private and institutional investors with about 0.16 trading days to cover. More on BIO Key International
Moving against BIO Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BIO Stock Highlights
| MD ViceChairman | Kwok Wong | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Systems Software, Security & Protection Services, Information Technology, NASDAQ Composite, Information Technology, Software, Security & Protection Services, Industrials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBIO Key can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BIO Key's financial leverage. It provides some insight into what part of BIO Key's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
BIO Key International (BKYI) is traded on NASDAQ Exchange in USA. It is located in 101 Crawfords Corner Road, Holmdel, NJ, United States, 07753 and employs 43 people. BIO Key is listed under Systems Software category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M. BIO Key International conducts business under Software sector and is part of Information Technology industry. The entity has 3.11 M outstanding shares of which 865.18 K shares are currently shorted by private and institutional investors with about 0.16 trading days to cover.
BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check BIO Key Probability Of Bankruptcy
Ownership AllocationBIO Key International shows 5.57 percent of its outstanding shares held by insiders and 5.02 percent owned by other corporate entities.
Check BIO Ownership Details
BIO Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | |
| Group One Trading, Lp | 2024-06-30 | 0.0 | |
| Geode Capital Management, Llc | 2024-09-30 | 0.0 | |
| Armistice Capital, Llc | 2024-09-30 | 250 K | |
| Tower Research Capital Llc | 2024-06-30 | 5.9 K | |
| Ubs Group Ag | 2024-06-30 | 2.4 K | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 262 | |
| Jpmorgan Chase & Co | 2024-06-30 | 71.0 | |
| Headlands Technologies Llc | 2024-09-30 | 16.0 | |
| Bank Of America Corp | 2024-06-30 | 14.0 | |
| Harbour Investments, Inc. | 2024-09-30 | 6.0 |
BIO Key Historical Income Statement
BIO Stock Against Markets
BIO Key Corporate Management
| Cecilia Welch | Chief Officer | Profile | |
| Akintunde Jeje | Managing Africa | Profile | |
| Alex Rocha | Managing EMEA | Profile | |
| Mira LaCous | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.